Co-expression of p53 and bcl-2 may correlate to the presence of Epstein-Barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma

Cancer Letters

Volumn 160, Issue 2, 2000, Pages 199-208

  Niemhom, Sopaporn ^a   Kitazawa, Sohei ^b   Murao, Shinichi ^b   Kunachak, Somyos ^a   Maeda, Sakan ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KOBE UNIVERSITY   (Japan)

Author keywords

bcl 2; Epstein Barr virus; Nasopharyngeal carcinoma; p53; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; VIRUS CARCINOGENESIS;

CARCINOMA; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION; GENES, BCL-2; GENES, P53; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMAN; IMMUNOHISTOCHEMISTRY; MUTATION; NASOPHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN P53; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPPORT, NON-U.S. GOV'T;

DNA VIRUSES; HUMAN HERPESVIRUS 4; MARTES PENNANTI;

EID: 0034727788     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00582-6     Document Type: Article

References (38)

1. An epidemiologic and clinical study of nasopharyngeal carcinoma
2. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration
3. Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma
4. Epstein-Barr virus and carcinomas: Undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus
5. Participation of p53 protein in the cellular response to DNA damage
6. Induction of apoptosis by wild-type p53 in human colon tumor-derived cell line
7. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of A 20 gene
8. p53 mutation in human cancers
9. Tumor suppressor genes. p53
10. Mutations clustered in exon 5 of the p53 gene in primary nasopharyngeal carcinomas from southeastern Asia
11. A molecular study of EBV DNA and p53 mutations in nasopharyngeal carcinoma of Saudi Arab patients
12. Alterations of the p53 gene in nasopharyngeal carcinoma
13. p53 mutation in human nasopharyngeal carcinomas
14. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma
15. p53 inactivating mutations in Chinese nasopharyngeal carcinoma
16. Assessment of p53 expression in nasopharyngeal carcinoma
17. p53 overexpression is different in Epstein-Barr virus-associated and Epstein-Barr virus-negative carcinoma
18. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation
19. bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
20. Distinctive chromosomal abnormalities in histologic subtypes of non-hodgkin's lymphoma
21. Preferential linkage of bcl-2 to immunoglobulin light-chain gene in chronic lymphocytic leukemia
22. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
23. bcl-2 protein in non-small-cell lung carcinoma
24. Bcl-2 proto-oncogene expression in Epstein-Barr virus associated nasopharyngeal carcinoma
25. Down regulation of bcl-2 by p53 in nasopharyngeal carcinoma and lack of detection of its specific t(14;18) chromosomal translocation in fixed tissues
26. Analysis of bcl-2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia, and nasopharyngeal carcinoma: Association with p53 expression
27. Immunohistochemical expression of Bcl-2 oncoprotein in EBV-associated nasopharyngeal carcinoma correlated to histological type and survival
28. Cyclin/PCNA is the auxiliary protein of DNA polymerase δ
29. Increased nuclear cyclin/PCNA antigen staining of non s-phase transformed human amnion cells engaged in nucleotide excision DNA repair
30. Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis
31. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in human benign and malignant epithelial lesion of the parotid gland
32. The assesment of cellular proliferation by immunohistochemistry: A review of currently available methods and their application
33. Assessment of proliferating cell nuclear antigen in nasopharyngeal carcinoma tissue and its relation to clinical finding
34. Growth regulation of the PCNA gene
35. Effect of the SV 40 T antigen on the post-transcriptional regulation of the proliferating cell nuclear antigen and DNA polymerase-α genes
36. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression
37. PCR amplification from paraffin-embedded tissue: Effects of fixative and fixation time
38. Nonradioactive labelling the probe with digoxigenin by polymerase chain reaction